MXPA01007211A - Modulacion de la respuesta inmune por ribavirina. - Google Patents
Modulacion de la respuesta inmune por ribavirina.Info
- Publication number
- MXPA01007211A MXPA01007211A MXPA01007211A MXPA01007211A MXPA01007211A MX PA01007211 A MXPA01007211 A MX PA01007211A MX PA01007211 A MXPA01007211 A MX PA01007211A MX PA01007211 A MXPA01007211 A MX PA01007211A MX PA01007211 A MXPA01007211 A MX PA01007211A
- Authority
- MX
- Mexico
- Prior art keywords
- nucleoside
- stimulus
- ribavirin
- cells
- immune system
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Transplantation (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Reproductive Health (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24136799A | 1999-01-29 | 1999-01-29 | |
| PCT/US1999/030490 WO2000044388A1 (en) | 1999-01-29 | 1999-12-20 | Modulation of immune response by ribavirin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA01007211A true MXPA01007211A (es) | 2002-05-06 |
Family
ID=22910442
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA01007211A MXPA01007211A (es) | 1999-01-29 | 1999-12-20 | Modulacion de la respuesta inmune por ribavirina. |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1146883A4 (hr) |
| JP (1) | JP2002535371A (hr) |
| KR (1) | KR20020023939A (hr) |
| CN (1) | CN1334736A (hr) |
| AU (1) | AU2483300A (hr) |
| BR (1) | BR9917090A (hr) |
| CA (1) | CA2357735A1 (hr) |
| CZ (1) | CZ20012519A3 (hr) |
| HK (1) | HK1040937A1 (hr) |
| HR (1) | HRP20010496A2 (hr) |
| HU (1) | HUP0200027A2 (hr) |
| IL (1) | IL144130A0 (hr) |
| MX (1) | MXPA01007211A (hr) |
| NO (1) | NO20013529L (hr) |
| PL (1) | PL364699A1 (hr) |
| RU (1) | RU2211698C2 (hr) |
| SI (1) | SI20802A (hr) |
| SK (1) | SK10092001A3 (hr) |
| WO (1) | WO2000044388A1 (hr) |
| ZA (1) | ZA200105595B (hr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7022830B2 (en) | 2000-08-17 | 2006-04-04 | Tripep Ab | Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| US6858590B2 (en) | 2000-08-17 | 2005-02-22 | Tripep Ab | Vaccines containing ribavirin and methods of use thereof |
| US6680059B2 (en) | 2000-08-29 | 2004-01-20 | Tripep Ab | Vaccines containing ribavirin and methods of use thereof |
| WO2002014362A2 (en) | 2000-08-17 | 2002-02-21 | Tripep Ab | A hepatitis c virus non-structural ns3/4a fusion gene |
| US20050182252A1 (en) | 2004-02-13 | 2005-08-18 | Reddy K. R. | Novel 2'-C-methyl nucleoside derivatives |
| AU2006339963B2 (en) * | 2006-03-14 | 2010-02-25 | Wholesome Biopharm Pty Ltd | Method and composition for treating allergic diseases |
| WO2009022236A2 (en) | 2007-08-16 | 2009-02-19 | Tripep Ab | Immunogen platform |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4211771A (en) * | 1971-06-01 | 1980-07-08 | Robins Ronald K | Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide |
| EP0038629A1 (en) * | 1980-04-17 | 1981-10-28 | Beecham Group Plc | Virazole derivatives, process for their preparation and use as antiviral agents |
| BE902199A (fr) * | 1984-10-29 | 1985-07-31 | Vira Tek Inc | Procede de traitement medical de maladies virales utilisant le 1-beta-d-ribofurannosyl-1, 2,4-triazole-3-carboxamide. |
| EP0262125B1 (en) * | 1986-03-27 | 1996-03-27 | Gensia, Inc. | AICA riboside for the prophylactic treatment of diseases with restricted blood flow. |
| US5030623A (en) * | 1986-03-27 | 1991-07-09 | The Regents Of The University Of California | Methods for increasing extracellular adenosine and for stabilizing mast cells |
| US5767097A (en) * | 1996-01-23 | 1998-06-16 | Icn Pharmaceuticals, Inc. | Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes |
| BR9707154A (pt) * | 1996-01-23 | 1999-05-25 | Icn Pharmaceuticals | Modulaç o da express o de citocina em th1/th2 por ribavirina e análogos de ribavirina em linfócitos t ativados |
| SK284054B6 (sk) * | 1996-10-16 | 2004-08-03 | Icn Pharmaceuticals, Inc. | Substituované triazolové nukleozidy, farmaceutický prostriedok s ich obsahom a ich použitie |
-
1999
- 1999-12-20 CA CA002357735A patent/CA2357735A1/en not_active Abandoned
- 1999-12-20 AU AU24833/00A patent/AU2483300A/en not_active Abandoned
- 1999-12-20 JP JP2000595690A patent/JP2002535371A/ja not_active Withdrawn
- 1999-12-20 IL IL14413099A patent/IL144130A0/xx unknown
- 1999-12-20 HU HU0200027A patent/HUP0200027A2/hu unknown
- 1999-12-20 BR BR9917090-6A patent/BR9917090A/pt not_active IP Right Cessation
- 1999-12-20 PL PL99364699A patent/PL364699A1/xx not_active Application Discontinuation
- 1999-12-20 CZ CZ20012519A patent/CZ20012519A3/cs unknown
- 1999-12-20 KR KR1020017009609A patent/KR20020023939A/ko not_active Application Discontinuation
- 1999-12-20 RU RU2001119056/14A patent/RU2211698C2/ru not_active IP Right Cessation
- 1999-12-20 SK SK1009-2001A patent/SK10092001A3/sk unknown
- 1999-12-20 SI SI9920099A patent/SI20802A/sl not_active IP Right Cessation
- 1999-12-20 EP EP99968159A patent/EP1146883A4/en not_active Withdrawn
- 1999-12-20 MX MXPA01007211A patent/MXPA01007211A/es unknown
- 1999-12-20 CN CN99815897A patent/CN1334736A/zh active Pending
- 1999-12-20 WO PCT/US1999/030490 patent/WO2000044388A1/en not_active Application Discontinuation
-
2001
- 2001-07-02 HR HR20010496A patent/HRP20010496A2/hr not_active Application Discontinuation
- 2001-07-06 ZA ZA200105595A patent/ZA200105595B/xx unknown
- 2001-07-17 NO NO20013529A patent/NO20013529L/no not_active Application Discontinuation
-
2002
- 2002-04-18 HK HK02102923.6A patent/HK1040937A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0200027A2 (en) | 2002-04-29 |
| BR9917090A (pt) | 2001-10-16 |
| CN1334736A (zh) | 2002-02-06 |
| WO2000044388A1 (en) | 2000-08-03 |
| CA2357735A1 (en) | 2000-08-03 |
| RU2211698C2 (ru) | 2003-09-10 |
| NO20013529D0 (no) | 2001-07-17 |
| SI20802A (sl) | 2002-08-31 |
| HK1040937A1 (zh) | 2002-06-28 |
| ZA200105595B (en) | 2002-10-07 |
| AU2483300A (en) | 2000-08-18 |
| CZ20012519A3 (cs) | 2002-05-15 |
| IL144130A0 (en) | 2002-05-23 |
| PL364699A1 (en) | 2004-12-13 |
| HRP20010496A2 (en) | 2003-08-31 |
| JP2002535371A (ja) | 2002-10-22 |
| EP1146883A1 (en) | 2001-10-24 |
| KR20020023939A (ko) | 2002-03-29 |
| SK10092001A3 (sk) | 2002-02-05 |
| EP1146883A4 (en) | 2004-11-24 |
| NO20013529L (no) | 2001-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6455508B1 (en) | Methods for treating diseases with tirazole and pyrrolo-pyrimidine ribofuranosyl nucleosides | |
| US6509320B1 (en) | Purine L-nucleosides, analogs and uses thereof | |
| CN100528173C (zh) | 4′-取代的核苷 | |
| AU669702B2 (en) | Enantiomeric hydroxylated xanthine compounds | |
| CN1286258A (zh) | 嘌呤l－核苷、其类似物及其用途 | |
| US6423695B1 (en) | Cytokine related treatments of disease | |
| US6455690B1 (en) | L-8-oxo-7-propyl-7,8-dihydro-(9H)-guanosine | |
| US20020187945A1 (en) | Modulation of immune response by ribavirin | |
| KR100263943B1 (ko) | 조혈 개선을 위한 옥시푸린 뉴클레오시드 및 그의 동종체 및 그의 아실 유도체 | |
| MXPA01007211A (es) | Modulacion de la respuesta inmune por ribavirina. | |
| AU732120B2 (en) | Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis | |
| EP0998293A1 (en) | Cytokine related treatments of disease | |
| US7056895B2 (en) | Tirazole nucleoside analogs and methods for using same | |
| WO2013056510A1 (zh) | 脱氧核苷与核苷组合在制备肿瘤药物中的应用 | |
| EP1132393A1 (en) | L-Ribavirin and uses thereof | |
| EP1072607A2 (en) | Purine L-nucleosides, analogs and uses therof | |
| NZ512879A (en) | Modulation of immune response by Ribavirin | |
| NZ505531A (en) | 7-Propyl-8-oxo-alpha or beta-L-guanine alpha or beta-L-nucleoside | |
| AU751742B2 (en) | Purine L-nucleosides, analogs and uses thereof | |
| EP1329220A1 (en) | Cytokine related treatments of disease | |
| NZ505553A (en) | 8-substituted alpha or beta L-guanosine analogs and uses thereof | |
| CA2323791A1 (en) | Purine l-nucleosides, analogs and uses thereof | |
| MXPA99006418A (es) | Tratamiento de enfermedad ralacionados concitosina | |
| CA2322053A1 (en) | Novel nucleosides |